623 related articles for article (PubMed ID: 33968010)
1. Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients.
Mortaz E; Tabarsi P; Jamaati H; Dalil Roofchayee N; Dezfuli NK; Hashemian SM; Moniri A; Marjani M; Malekmohammad M; Mansouri D; Varahram M; Folkerts G; Adcock IM
Front Immunol; 2021; 12():592727. PubMed ID: 33968010
[TBL] [Abstract][Full Text] [Related]
2. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
[TBL] [Abstract][Full Text] [Related]
3. Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.
Udomsinprasert W; Jittikoon J; Sangroongruangsri S; Chaikledkaew U
J Clin Immunol; 2021 Jan; 41(1):11-22. PubMed ID: 33128665
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy.
Popadic V; Klasnja S; Milic N; Rajovic N; Aleksic A; Milenkovic M; Crnokrak B; Balint B; Todorovic-Balint M; Mrda D; Zdravkovic D; Toskovic B; Brankovic M; Markovic O; Bjekic-Macut J; Djuran P; Memon L; Brajkovic M; Todorovic Z; Hadzi-Djokic J; Jovanovic I; Nikolic D; Zdravkovic M
Oxid Med Cell Longev; 2021; 2021():6648199. PubMed ID: 33968298
[TBL] [Abstract][Full Text] [Related]
5. Association between serum inflammatory parameters and the disease severity in COVID-19 patients.
Mardani R; Namavar M; Ghorbi E; Shoja Z; Zali F; Kaghazian H; Aghasadeghi MR; Sadeghi SA; Sabeti S; Darazam IA; Ahmadi N; Mousavi-Nasab SD
J Clin Lab Anal; 2022 Jan; 36(1):e24162. PubMed ID: 34874079
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Inflammatory Response to Severe COVID-19 Illness.
McElvaney OJ; McEvoy NL; McElvaney OF; Carroll TP; Murphy MP; Dunlea DM; Ní Choileáin O; Clarke J; O'Connor E; Hogan G; Ryan D; Sulaiman I; Gunaratnam C; Branagan P; O'Brien ME; Morgan RK; Costello RW; Hurley K; Walsh S; de Barra E; McNally C; McConkey S; Boland F; Galvin S; Kiernan F; O'Rourke J; Dwyer R; Power M; Geoghegan P; Larkin C; O'Leary RA; Freeman J; Gaffney A; Marsh B; Curley GF; McElvaney NG
Am J Respir Crit Care Med; 2020 Sep; 202(6):812-821. PubMed ID: 32584597
[No Abstract] [Full Text] [Related]
7. Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19.
Vassiliou AG; Dimopoulou I; Jahaj E; Keskinidou C; Mastora Z; Orfanos SE; Kotanidou A
In Vivo; 2021; 35(2):1295-1298. PubMed ID: 33622933
[TBL] [Abstract][Full Text] [Related]
8. Cytokine storm in severe COVID-19 pneumonia.
Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
[TBL] [Abstract][Full Text] [Related]
9. Silent hypoxia: higher NO in red blood cells of COVID-19 patients.
Mortaz E; Malkmohammad M; Jamaati H; Naghan PA; Hashemian SM; Tabarsi P; Varahram M; Zaheri H; Chousein EGU; Folkerts G; Adcock IM
BMC Pulm Med; 2020 Oct; 20(1):269. PubMed ID: 33066765
[TBL] [Abstract][Full Text] [Related]
10. Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis.
Gorham J; Moreau A; Corazza F; Peluso L; Ponthieux F; Talamonti M; Izzi A; Nagant C; Ndieugnou Djangang N; Garufi A; Creteur J; Taccone FS
PLoS One; 2020; 15(12):e0244628. PubMed ID: 33382773
[TBL] [Abstract][Full Text] [Related]
11. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS).
Hashemian SM; Shafigh N; Afzal G; Jamaati H; Tabarsi P; Marjani M; Malekmohammad M; Mortazavi SM; Khoundabi B; Mansouri D; Moniri A; Hajifathali A; Roshandel E; Mortaz E; Adcock IM
Pulmonology; 2021; 27(6):486-492. PubMed ID: 33358260
[TBL] [Abstract][Full Text] [Related]
12. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
13. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
Front Immunol; 2021; 12():668725. PubMed ID: 34276659
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.
Satış H; Özger HS; Aysert Yıldız P; Hızel K; Gulbahar Ö; Erbaş G; Aygencel G; Guzel Tunccan O; Öztürk MA; Dizbay M; Tufan A
Cytokine; 2021 Jan; 137():155302. PubMed ID: 33002740
[TBL] [Abstract][Full Text] [Related]
15. Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study.
Sancho Ferrando E; Hanslin K; Hultström M; Larsson A; Frithiof R; Lipcsey M;
Cytokine; 2022 Jan; 149():155727. PubMed ID: 34628127
[TBL] [Abstract][Full Text] [Related]
16. Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico.
Avila-Nava A; Cortes-Telles A; Torres-Erazo D; López-Romero S; Chim Aké R; Gutiérrez Solis AL
Cytokine; 2021 Jul; 143():155543. PubMed ID: 33896708
[TBL] [Abstract][Full Text] [Related]
17. Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds.
Elnosary ME; Shreadah MA; Ashour ML; Nabil-Adam A
Int Immunopharmacol; 2024 Jan; 126():111072. PubMed ID: 38006751
[TBL] [Abstract][Full Text] [Related]
18. Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes.
Fernández S; Moreno-Castaño AB; Palomo M; Martinez-Sanchez J; Torramadé-Moix S; Téllez A; Ventosa H; Seguí F; Escolar G; Carreras E; Nicolás JM; Richardson E; García-Bernal D; Carlo-Stella C; Moraleda JM; Richardson PG; Díaz-Ricart M; Castro P
Shock; 2022 Jan; 57(1):95-105. PubMed ID: 34172614
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy.
Campi I; Gennari L; Merlotti D; Mingiano C; Frosali A; Giovanelli L; Torlasco C; Pengo MF; Heilbron F; Soranna D; Zambon A; Di Stefano M; Aresta C; Bonomi M; Cangiano B; Favero V; Fatti L; Perego GB; Chiodini I; Parati G; Persani L
BMC Infect Dis; 2021 Jun; 21(1):566. PubMed ID: 34126960
[TBL] [Abstract][Full Text] [Related]
20. Abnormal Transcript Levels of Cytokines Among Iranian COVID-19 Patients.
Samsami M; Fatemi A; Jalili Khoshnoud R; Kohansal K; Hussen BM; Soghala S; Taheri M; Ghafouri-Fard S
J Mol Neurosci; 2022 Jan; 72(1):27-36. PubMed ID: 34855144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
